PCT brand logo

Manufacturing Transformation Focused on Cell Therapy Since 1999

Hitachi Chemical Advanced Therapeutics Solutions has two decades of experience utilizing the PCT global service platform, which is solely focused on cell therapy CDMO services at cGMP standards—including clinical manufacturing, commercial manufacturing, and manufacturing development.

Featured Content

Check Out Our: Meet Our Team Behind the Cells Ft. Courtney LeBlon

We pride ourselves on our exceptional team of cell therapy development and manufacturing experts. To kick off the "Meet Our Team Behind the Cells" series, we're introducing you to one of our team members, Courtney LeBlon, Director of Manufacturing Sciences and Technology. 

Learn More

Check Out Our: The Road to Manufacturing Commercially Viable Cell Therapies

Working through the four facets of Development by Design at an early stage can provide significant cost and time advantages as a cell therapy developer moves further along the clinical development process. 

Learn More

Check Out Our: Dr. Preti Answers Questions in ISCT’s Talking with Giants

Recently, the International Society for Cell & Gene Therapy (ISCT) conducted an interview with Dr. Preti to discuss the past, present, and future of cell and gene therapy. This interview was highlighted in ISCT’s Talking with Giants segment. Check out some of the highlights from the interview.

Learn More
Phacilitate-leaders-world-logo

Check Out Our: 2020 Phacilitate Leaders World & World Stem Cell Summit

Join our experts for another year at the Phacilitate Leaders World and World Stem Cell Summit to discuss aspects of the advanced therapies industry. This year's conference will be held in Miami and you do not want to miss out. Check out the PLW site for registration details. 

Learn More

Our mindset and tagline, Manufacturing Transformation, embodies both our commitment to help customers achieve and efficiently deliver life-changing, cell-based therapeutics and to transform cell therapy manufacturing to optimize and enable the future-state.

ROBERT PRETI, PHD | CEO & PRESIDENT

50

Technology Transfers
Analytical_Development_Icon.png

7,500

Patients Treated
Analytical_Development_Icon.png

125

Clients Served
Analytical_Development_Icon.png
Subscribe to our blog for instant updates on challenges and trends in cell therapy development, manufacturing and commercialization.

© 2019 Hitachi Chemical Advanced Therapeutics Solutions, LLC